← All stocks

Milestone Pharmaceuticals Inc.

MIST Net selling
CIK 0001408443 #4195 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.18M
$180.37K on a plan · $159.11K straight out of an exercise
Sold at will
$836.69K
5 of 13 sales
Net
−$1.18M
−$836.69K against sales at will

By person

8 insiders · 13 transactions
1.5×

Joseph Oliveto holds only 1.5 times base salary in stock. $1.01M of shares against $649.64K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Oliveto last reported holding, valued at $2.26, the price Common Shares was last bought or sold at on the open market here, on 16 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Oliveto Joseph
President and CEO
$555.68K (5)
−$555.68K
446,244
$1.01M
+59.1%
Bharucha David
Chief Medical Officer
$158.21K (2)
−$158.21K
113,181
$255.79K
+1,032%
Hasija Amit
CFO & EVP of Corp. Development
$158.21K (2)
−$158.21K
99,848
$225.66K
Nelson Jeffrey Edward
Chief Operating Officer
$158.21K (2)
−$158.21K
49,848
$112.66K
Muller Lorenz
Chief Commercial Officer
$145.85K (2)
−$145.85K
205,406
$464.22K
+89.5%
PAPA JOSEPH C
Director
100,000
$226.00K
Wills Robert James
Director
65,000
$146.90K
+333.3%
Liebert Debra K.
Director
16,793
$37.95K
+13,123%

No percentages here. This company's share count has moved by a factor of 2.3 over the window, from 53,327,908 to 124,497,980 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 5
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 852,000
History held since 9 May 2019